Indica Labs Announces Part 2 of Masterclass Webinar Scheduled for May
Date: 25 May 2023
Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST
Location: Webinar
REGISTER NOW
Learn how to tackle challenging multiplex assays using advanced techniques and workflow.
SUMMARY
LEARNING OBJECTIVES
- Advance your multiplex IHC module analysis with HALO AI cell segmentation and phenotyping options
- Learn how to perform a serial stain image analysis workflow to convert multiplexed immunohistochemistry to pseudo-fluorescent images
- Learn advantages of AI-based phenotyping and how to perform it with HALO AI
PRESENTERS
Dr. Kate Lillard Tunstall
Chief Scientific Officer, Indica Labs
Kate Lillard received her Ph.D. in Molecular Genetics and Biochemistry from the University of Cincinnati Medical Center, followed by a Howard Hughes postdoctoral fellowship at the University of Texas Southwestern Medical Center. While conducting research in the area of stem cell biology and oncology as a graduate and postdoctoral fellow, Dr. Lillard developed a keen interest in IHC which led to her joining Aperio in 2007 where she supported and then managed image analysis products for digital pathology. After acquisition of Aperio by Leica in late 2012, Dr. Lillard joined Indica Labs as Chief Scientific Officer where she supports, promotes, and helps guide the development of digital pathology image analysis solutions for the life sciences.
REGISTER NOW
SOURCE: Indica Labs
- Related Categories:
- Artificial Intelligence
- Digital Pathology News
- Education
- Webinars
next article
Biofidelity: Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA CAMBRIDGE,...